Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate 16729-0550
Product NDC
16729-0550- Manufacturer
- Accord Healthcare, Inc
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- September 1, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA209069
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 8 mg/1 |
| Naloxone Hydrochloride Dihydrate | 2 mg/1 |
Drug Class
Opioid Antagonist [EPC]Opioid Antagonists [MoA]Partial Opioid Agonist [EPC]
Packaging Options(1)
30 TABLET in 1 BOTTLE, PLASTIC (16729-550-10)
External Resources